Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002033801-25-000002
Filing Date
2025-03-18
Accepted
2025-03-18 17:13:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4743
  Complete submission text file 0002033801-25-000002.txt   6246
Mailing Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701
Business Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 919-314-5512
PRECISION BIOSCIENCES INC (Subject) CIK: 0001357874 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90975 | Film No.: 25749515
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 12221 MERIT DRIVE SUITE 620 DALLAS TX 75251
Business Address
Weinstein Benjamin (Filed by) CIK: 0002033801 (see all company filings)

Type: SCHEDULE 13G